Form 4: Kestra Medical Technologies Director Sells Shares
Insider Transaction (Form 4)
Mary Kay Ladone, a Director of Kestra Medical Technologies, Ltd., sold 3,908 shares of common stock on September 8, 2026 for $25.20 per share.
Summary
- Open-market sale: disposed of 3,908 Common Shares at $25.20 ($98,464) on September 8, 2026; holds 37,507 after (Direct).
- Grant/award: acquired 7,217 Common Shares on September 9, 2026; holds 44,724 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $98,464 of stock on the open market.
Insider Transactions
Mary Kay Ladone — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Open-market sale | Common Shares | 3,908 | $25 | $98.5K | 37,507 |
| 2026-09-09 | Grant/award | Common Shares | 7,217 | — | — | 44,724 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Open-market sale (3,908 shares) |
| 2026-09-09 | Grant/award (7,217 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., bearish, Mary Kay Ladone
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.